Coming full circle: thirty years of paediatric fluid resuscitation

N J Glassford1, B Gelbart2, R Bellomo3

  • 1Registrar and Clinical Research Fellow, Department of Intensive Care, Austin Hospital, PhD Candidate, Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Melbourne, Victoria.

Insights

Fluid bolus therapy (FBT) in septic children has limited evidence for benefit, prompting a review of current practices. Further research is needed to optimize FBT strategies and patient outcomes in pediatric intensive care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Septic Shock Management
  • Fluid Resuscitation Research

Background:

  • Fluid bolus therapy (FBT) is a standard treatment for septic children.
  • Evidence supporting liberal FBT in developed nations is limited.
  • The FEAST trial influenced FBT guidelines, particularly in resource-poor settings.

Purpose of the Study:

  • To evaluate the current evidence base for FBT in pediatric sepsis.
  • To identify challenges and opportunities in conducting FBT research in critically ill children.
  • To advocate for further investigation into optimal FBT strategies and alternatives.

Main Methods:

  • Review of existing clinical research on FBT in pediatric sepsis.
  • Analysis of the impact of the FEAST trial on clinical practice and guidelines.
  • Discussion of modern clinical trial methodologies for critically ill pediatric populations.

Main Results:

  • Limited evidence exists for the independent benefit of liberal FBT in developed countries.
  • Fluid accumulation from FBT is associated with pulmonary pathology in children.
  • Post-FEAST trials continue to explore liberal FBT despite potential risks.

Conclusions:

  • There is a need for robust, powered trials examining FBT efficacy versus alternatives in pediatric emergency and ICU settings.
  • Modern trial designs may overcome challenges in researching interventions for critically ill children.
  • Re-evaluation of FBT is warranted due to its widespread use and potential for harm.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
864
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.4K